Analyst Reco. Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
18.55 ^USD	+0.71%		+4.10%	+28.64%

Apr. 09	Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating	MT
Apr. 08	Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating	Apr. 09	MT
Goldman Sachs Adjusts Price Target on Organon to $18 From $16, Keeps Neutral Rating	Feb. 20	MT
Piper Sandler Adjusts Organon & Co.'s Price Target to $22 From $32, Maintains Overweight Rating	Nov. 22	MT
Goldman Sachs Downgrades Organon to Neutral From Buy, Cuts Price Target to $16 From $33	Nov. 03	MT
Morgan Stanley Adjusts Price Target on Organon to $22 From $27, Maintains Equal-Weight Rating	23-10-11	MT
Barclays Initiates Organon With Overweight Rating, Price Target is $28	23-09-21	MT
Morgan Stanley Adjusts Price Target on Organon to $27 From $25, Maintains Equal-Weight Rating	23-08-09	MT
Morgan Stanley Cuts Price Target on Organon to $25 From $26, Maintains Equal-Weight Rating	23-05-08	MT
Raymond James Starts Organon & Co. at Outperform With $33 Price Target	23-03-16	MT
Hot Wholesale Prices Print Saps Appetite for US Equities as Concern Mounts Rates Headed Higher	23-02-16	MT
Marketmind: Growth trumps rates	23-02-16	RE
Morgan Stanley Lowers Price Target for Organon to $24 From $27, Keeps Equalweight Rating	22-11-04	MT
BofA Securities Downgrades Organon to Underperform From Neutral, Adjusts Price Target to $25 From $37	22-10-14	MT
Morgan Stanley Lowers Organon & Co's Price Target to $27 From $35, Maintains Equalweight Rating	22-10-12	MT
Piper Sandler Upgrades Organon & Co. to Overweight From Neutral, Adjusts Price Target to $34 From $37	22-09-06	MT
Goldman Sachs Trims Organon & Co's Price Target to $38 From $41, Keeps Buy Rating	22-08-08	MT
BofA Securities Downgrades Organon to Neutral From Buy, Adjusts Price Target to $37 From $40	22-08-05	MT
Goldman Sachs Adjusts Price Target for Organon & Co to $41 From $42, Maintains Buy Rating	22-07-19	MT
Morgan Stanley Trims Organon & Co's Price Target to $34 From $35, Maintains Equalweight Rating	22-07-08	MT
Goldman Sachs Starts Organon & Co. at Buy With $40 Price Target	22-04-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Organon & Co.

Equities

OGN

US68622V1061

Analyst Reco.

Filters